• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation.

作者信息

Korell Felix, Schreck Nicholas, Müller-Tidow Carsten, Dreger Peter, Luft Thomas

机构信息

Department of Hematology and Oncology, University Hospital Heidelberg, Heidelberg, Germany.

Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.

出版信息

Intensive Care Med. 2022 Jun;48(6):753-755. doi: 10.1007/s00134-022-06676-3. Epub 2022 Apr 16.

DOI:10.1007/s00134-022-06676-3
PMID:35429256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9012907/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f390/9205824/92f8424568e3/134_2022_6676_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f390/9205824/92f8424568e3/134_2022_6676_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f390/9205824/92f8424568e3/134_2022_6676_Fig1_HTML.jpg

相似文献

1
Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation.异基因干细胞移植前的EASIX与移植后脓毒症
Intensive Care Med. 2022 Jun;48(6):753-755. doi: 10.1007/s00134-022-06676-3. Epub 2022 Apr 16.
2
Validation of pre-conditioning EASIX for prediction of sepsis after allogeneic stem cell transplantation.预处理EASIX对异基因干细胞移植后脓毒症预测的验证。
Intensive Care Med. 2023 Nov;49(11):1408-1410. doi: 10.1007/s00134-023-07193-7. Epub 2023 Aug 23.
3
EASIX and mortality after allogeneic stem cell transplantation.异体造血干细胞移植后的EASIX与死亡率
Bone Marrow Transplant. 2020 Mar;55(3):553-561. doi: 10.1038/s41409-019-0703-1. Epub 2019 Sep 26.
4
Limits of the Glasgow Coma Scale When Assessing for Sepsis in Allogeneic Hematopoietic Cell Transplant Recipients.格拉斯哥昏迷评分在评估异基因造血细胞移植受者脓毒症中的局限性。
Nurs Res. 2021;70(5):399-404. doi: 10.1097/NNR.0000000000000521.
5
Liver disease during and after hematopoietic stem cell transplantation in adults: a single-center Egyptian experience.成人造血干细胞移植期间和之后的肝脏疾病：单中心埃及经验。
J Egypt Natl Canc Inst. 2020 Feb 22;32(1):11. doi: 10.1186/s43046-020-0020-1.
6
Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation.移植前 EASIX 预测异基因造血细胞移植患者入住重症监护病房。
Blood Adv. 2021 Sep 14;5(17):3418-3426. doi: 10.1182/bloodadvances.2021004812.
7
Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation.入院时内皮细胞激活和应激指数（EASIX）可预测异基因造血干细胞移植受者的液体超负荷。
Biol Blood Marrow Transplant. 2020 May;26(5):1013-1020. doi: 10.1016/j.bbmt.2020.01.028. Epub 2020 Feb 9.
8
High EASIX score is an independent predictor of non-relapse mortality in patients with CMML undergoing allogeneic stem cell transplant.高EASIX评分是接受异基因干细胞移植的慢性粒-单核细胞白血病患者非复发死亡率的独立预测因素。
Bone Marrow Transplant. 2022 Dec;57(12):1842-1844. doi: 10.1038/s41409-022-01829-w. Epub 2022 Sep 21.
9
Clinical impact of pre-transplant diastolic function on outcome after allogeneic hematopoietic SCT.移植前舒张功能对异基因造血干细胞移植后结局的临床影响。
Bone Marrow Transplant. 2014 Sep;49(9):1241-3. doi: 10.1038/bmt.2014.126. Epub 2014 Jun 16.
10
Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients.异基因造血干细胞移植受者移植前后的血流感染率及相关死亡率
Transpl Infect Dis. 2005 Mar;7(1):11-7. doi: 10.1111/j.1399-3062.2005.00088.x.

引用本文的文献

1
Endothelial Activation and Stress Index (EASIX): A Prognostic Marker for Mortality After Acute Graft-Versus-Host Disease and Endothelial Complications.内皮激活与应激指数（EASIX）：急性移植物抗宿主病及内皮并发症后死亡率的预后标志物。
Methods Mol Biol. 2025;2907:85-89. doi: 10.1007/978-1-0716-4430-0_4.
2
The EASIX score as a predictor of sinusoidal obstruction syndrome and nonrelapse mortality in paediatric patients receiving allogeneic haematopoietic stem cell transplantation.EASIX评分作为接受异基因造血干细胞移植的儿科患者窦性阻塞综合征和无复发死亡率的预测指标。
Bone Marrow Transplant. 2025 Mar;60(3):346-352. doi: 10.1038/s41409-024-02489-8. Epub 2024 Dec 10.
3
EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma.
EASIX 指导下 ide-cel 治疗复发/难治性多发性骨髓瘤患者的 CAR T 细胞治疗后并发症和结局的风险分层。
J Immunother Cancer. 2024 Oct 7;12(10):e009220. doi: 10.1136/jitc-2024-009220.
4
EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapy.EASIX和m-EASIX可预测CD19嵌合抗原受体T细胞疗法后儿科和青少年及年轻成人患者的CRS和ICANS。
Blood Adv. 2025 Jan 28;9(2):270-279. doi: 10.1182/bloodadvances.2024014027.
5
EASIX (endothelial activation and stress index) predicts mortality in patients with coronary artery disease.内皮激活与应激指数（EASIX）可预测冠心病患者的死亡率。
Clin Res Cardiol. 2024 Sep 10. doi: 10.1007/s00392-024-02534-y.
6
Association between Age-Adjusted Endothelial Activation and Stress Index and Intensive Care Unit Mortality in Patients with Severe COVID-19.年龄校正的内皮激活与应激指数和重症 COVID-19 患者重症监护病房死亡率之间的关联
Tuberc Respir Dis (Seoul). 2024 Oct;87(4):524-531. doi: 10.4046/trd.2024.0081. Epub 2024 Jul 24.
7
Improving the EASIX' predictive power for NRM in adults undergoing allogeneic hematopoietic cell transplantation.提高EASIX对接受异基因造血细胞移植的成年人非复发死亡率的预测能力。
Bone Marrow Transplant. 2024 Jul;59(7):1022-1024. doi: 10.1038/s41409-024-02267-6. Epub 2024 Mar 23.
8
Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy.改良 EASIX 评分可预测 CLL1 CAR-T 细胞治疗后急性髓系白血病患者发生严重 CRS/ICANS。
Ann Hematol. 2024 Mar;103(3):969-980. doi: 10.1007/s00277-024-05617-y. Epub 2024 Jan 12.
9
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study.内皮细胞激活和应激指数（EASIX）预测异基因干细胞移植后死亡率：一项前瞻性研究。
J Immunother Cancer. 2024 Jan 9;12(1):e007635. doi: 10.1136/jitc-2023-007635.
10
The EAS(E)IX of predicting sepsis after allogeneic hematopoietic cell transplantation.预测异基因造血细胞移植后脓毒症的EAS（E）IX。
Intensive Care Med. 2023 Nov;49(11):1386-1387. doi: 10.1007/s00134-023-07242-1. Epub 2023 Oct 24.